Effect of dietary sesamin on metabolic fate of an exogenous linolelaidic acid in perfused rat liver.
To estimate the relative significance of exogenous and endogenous fatty acid substrates in decreasing hepatic triacylglycerol secretion after sesamin feeding, livers from rats fed diets supplemented with and without sesamin (sesamin: episesamin, 1:1, w/w) were perfused in the presence and absence of an exogenous di-trans isomer of linoleic acid (linolelaidic acid, trans,trans-9,12-octadecadienoic acid). Both exogenous trans fatty acid and dietary sesamin, as compared with respective controls, resulted in a marked increase in hepatic ketogenesis; however, the beta-hydroxybutyrate to acetoacetate ratio was elevated by exogenous fatty acid and decreased by dietary sesamin. On the other hand, hepatic secretions of triacylglycerol, phospholipid and cholesterol were markedly lowered in rats fed sesamin, especially when exogenous fatty acid substrate was provided. The relative significance of the exogenous fatty acid was observed in the dietary sesamin-induced decrease in hepatic secretion of triacylglycerol. These results suggest that increased fatty acid oxidation by dietary sesamin, as reflected by enhanced ketone body production, leads to decreased partition of fatty acid substrates to the esterification pathways, and this in turn reduces the synthesis and secretion of triacylglycerol. The altered metabolism of exogenous fatty acids in the liver was therefore a major determinant for the synthesis and secretion of triacylglycerol.
Fukuda
N
N
Department of Biological Resource Sciences, Faculty of Agriculture, Miyazaki University, Japan.
Zhang
L
L
Kodama
M
M
Sakono
M
M
Ide
T
T
Yamamoto
K
K
Sugano
M
M
D000818:Animals; D004032:Diet; D004149:Dioxoles / Q000008:administration & dosage / Q000494:pharmacology*; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007657:Ketone Bodies / Q000096:biosynthesis; D017705:Lignans / Q000008:administration & dosage / Q000494:pharmacology*; D019787:Linoleic Acid / Q000378:metabolism*; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000032:analysis / Q000378:metabolism
D004149:Dioxoles; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D007657:Ketone Bodies; D017705:Lignans; D014280:Triglycerides; D019787:Linoleic Acid; C054125:sesamin